MedTrace Logo

Adjuvanted Inactivated Vaccine Versus Inactivated Influenza Vaccine in Hutterite Children

NCT02871206 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 3425

Last updated 2024-11-21

No results posted yet for this study

Summary

This study is a randomized controlled trial (RCT) comparing adjuvanted influenza vaccine (AV) to unadjuvanted inactivated influenza vaccine (IIV). Children in Hutterite colonies in Alberta and Saskatchewan will receive AV or IIV. The goal of this study is to determine whether the AV vaccine, can provide increased community-wide protection.

Conditions

Interventions

BIOLOGICAL

Fluad

BIOLOGICAL

Fluzone

Sponsors & Collaborators

  • University of Calgary

    collaborator OTHER

  • University of Saskatchewan

    collaborator OTHER

  • McMaster University

    lead OTHER

Principal Investigators

  • Mark Loeb, MD, MSc. · McMaster University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2019-06-30
Completion
2019-07-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02871206 on ClinicalTrials.gov